ASA's guidance on the safe use of ketamine for mental health disorders makes news

News of ASA's patient safety guidance for ketamine’s use as a therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders has been featured by more than 100 news outlets, including U.S. News & World Report, Becker’s ASC Review and Healio.com.  “We’ve become aware that there are some places in the country where people can have ketamine sent to their homes; for those of us who know how potent of a drug ketamine is, the proposition that somebody could be administering it at home is scary,” ASA Immediate Past President Ronald L. Harter, MD, FASA, told Healio.